Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Modified release formulations for oprozomib

Modified release formulations for oprozomib

US Patent 9295708 · Granted Mar 29, 2016

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Peptide epoxyketone proteasome inhibitors in combination with PIM kinase inhibit2024
Dosing regimens for 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)me2024
Immunoglobulin expression levels as biomarker for proteasome inhibitor response2020
Combination therapy with peptide epoxyketones2020
Combination therapy with peptide epoxyketones2020
Tablets comprising 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)met2019
Cyclodextrin complexation methods for formulating peptide proteasome inhibitors2018
Liposomal compositions of epoxyketone-based proteasome inhibitors2018
Liposomal compositions of epoxyketone-based proteasome inhibitors2018
Combination therapy with peptide epoxyketones2016
Use of peptide epoxyketones for metastasis suppression2014